GlassScriptPhysician profile
Marina Babiy
NPI 1699757765
$3,342.69
in general payments reported to CMS, 2019-2025
12 companies · $26.07 in 2025
The $26.07 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $472 · 2021: $210 · 2022: $432 · 2023: $1,007 · 2024: $502 · 2025: $26.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,202.73 | 2022-2023 | Xeomin |
| Horizon Therapeutics Plc | $462.62 | 2019-2021 | |
| Abbvie INC. | $400.16 | 2023-2025 | Botox |
| Allergan, INC. | $333.87 | 2019-2022 | |
| Galderma Laboratories, L.P. | $322.37 | 2019 | |
| Revance Therapeutics, INC. | $172.82 | 2024 | Daxxify |
| Scilex Pharmaceuticals INC. | $153.88 | 2019-2023 | Ztlido |
| Pfizer INC. | $89.42 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $77.48 | 2020-2021 | |
| Zyla Life Sciences, INC. | $54.54 | 2019-2020 | |
| Depuy Synthes Sales INC. | $52.43 | 2021-2023 | Orthovisc |
| Fidia Pharma USA INC. | $20.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Babiy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.